These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26022996)

  • 21. Altered expression of mRNA profiles in blood of early-onset schizophrenia.
    Xu Y; Yao Shugart Y; Wang G; Cheng Z; Jin C; Zhang K; Wang J; Yu H; Yue W; Zhang F; Zhang D
    Sci Rep; 2016 Jan; 6():16767. PubMed ID: 26733343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment.
    Hrovatin K; Kunej T; Dolžan V
    Am J Med Genet B Neuropsychiatr Genet; 2020 Mar; 183(2):113-127. PubMed ID: 31674148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.
    Dong E; Dzitoyeva SG; Matrisciano F; Tueting P; Grayson DR; Guidotti A
    Biol Psychiatry; 2015 Mar; 77(6):589-96. PubMed ID: 25444166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
    Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
    J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Risk Factors for Schizophrenia.
    Modai S; Shomron N
    Trends Mol Med; 2016 Mar; 22(3):242-253. PubMed ID: 26869297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder.
    Ramos-Quiroga JA; Sánchez-Mora C; Casas M; Garcia-Martínez I; Bosch R; Nogueira M; Corrales M; Palomar G; Vidal R; Coll-Tané M; Bayés M; Cormand B; Ribasés M
    J Psychiatr Res; 2014 Feb; 49():60-7. PubMed ID: 24269040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders.
    Hoeffding LK; Duong LT; Ingason A; Rosengren A; Sorbanski E; Witt SH; Djurovic S; Andreassen OA; Hansen T; Werge T; Rasmussen HB
    Nord J Psychiatry; 2016; 70(4):276-9. PubMed ID: 26559242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of the schizophrenias: a model accounting for their persistence and myriad phenotypes.
    Boshes RA; Manschreck TC; Konigsberg W
    Harv Rev Psychiatry; 2012; 20(3):119-29. PubMed ID: 22716503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.
    Katsel P; Davis KL; Li C; Tan W; Greenstein E; Kleiner Hoffman LB; Haroutunian V
    Neuropsychopharmacology; 2008 Nov; 33(12):2993-3009. PubMed ID: 18322470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders.
    Xing J; Kimura H; Wang C; Ishizuka K; Kushima I; Arioka Y; Yoshimi A; Nakamura Y; Shiino T; Oya-Ito T; Takasaki Y; Uno Y; Okada T; Iidaka T; Aleksic B; Mori D; Ozaki N
    Sci Rep; 2016 Jun; 6():27491. PubMed ID: 27271353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution copy number variation analysis of schizophrenia in Japan.
    Kushima I; Aleksic B; Nakatochi M; Shimamura T; Shiino T; Yoshimi A; Kimura H; Takasaki Y; Wang C; Xing J; Ishizuka K; Oya-Ito T; Nakamura Y; Arioka Y; Maeda T; Yamamoto M; Yoshida M; Noma H; Hamada S; Morikawa M; Uno Y; Okada T; Iidaka T; Iritani S; Yamamoto T; Miyashita M; Kobori A; Arai M; Itokawa M; Cheng MC; Chuang YA; Chen CH; Suzuki M; Takahashi T; Hashimoto R; Yamamori H; Yasuda Y; Watanabe Y; Nunokawa A; Someya T; Ikeda M; Toyota T; Yoshikawa T; Numata S; Ohmori T; Kunimoto S; Mori D; Iwata N; Ozaki N
    Mol Psychiatry; 2017 Mar; 22(3):430-440. PubMed ID: 27240532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.
    Shen YC; Liao DL; Lu CL; Chen JY; Liou YJ; Chen TT; Chen CH
    Schizophr Res; 2010 Aug; 121(1-3):179-86. PubMed ID: 20541370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives.
    Kucukali CI; Aydin M; Ozkok E; Bilge E; Zengin A; Cakir U; Kara I
    Psychiatr Genet; 2010 Feb; 20(1):14-9. PubMed ID: 20010451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?
    Lee KW; Woon PS; Teo YY; Sim K
    Neurosci Biobehav Rev; 2012 Jan; 36(1):556-71. PubMed ID: 21946175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide rare copy number variation screening in ulcerative colitis identifies potential susceptibility loci.
    Saadati HR; Wittig M; Helbig I; Häsler R; Anderson CA; Mathew CG; Kupcinskas L; Parkes M; Karlsen TH; Rosenstiel P; Schreiber S; Franke A
    BMC Med Genet; 2016 Apr; 17():26. PubMed ID: 27037036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
    Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genes and environments in schizophrenia: The different pieces of a manifold puzzle.
    Réthelyi JM; Benkovits J; Bitter I
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2424-37. PubMed ID: 23628741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating Genetic Risk Loci Into Molecular Risk Mechanisms for Schizophrenia.
    Bray NJ; Hill MJ
    Schizophr Bull; 2016 Jan; 42(1):5-8. PubMed ID: 26536901
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk alleles of genes with monoallelic expression are enriched in gain-of-function variants and depleted in loss-of-function variants for neurodevelopmental disorders.
    Savova V; Vinogradova S; Pruss D; Gimelbrant AA; Weiss LA
    Mol Psychiatry; 2017 Dec; 22(12):1785-1794. PubMed ID: 28265118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis.
    Petronis A
    Biol Psychiatry; 2004 May; 55(10):965-70. PubMed ID: 15121478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.